Most Recent
A judge has ordered lawsuits by Fortnite owner Epic Games against Apple and Google to be heard together with class actions against the tech giants on behalf of app developers and customers who accuse them of distorting competition in the app marketplace.
A judge has questioned an argument by Optus that a report by Deloitte into a major data breach was protected by privilege, saying a press release by the teleco's boss belied the claim that the provision of legal advice was the report's chief purpose.
The OAIC has been dragged to court by the law firm that filed a class action-style complaint over the massive Optus data breach, after the privacy commissioner chose a competing representative complaint to move forward.
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.
After surviving multiple strike-out bids, a class action against Carnival over norovirus outbreaks on its Sun Princess cruise ship is still facing a “lurking" issue about a potential stay in relation to the claims of a subset of group members.
A class action against Carnival over norovirus outbreaks on its Sun Princess cruise ship has defeated the cruise operator’s second strike out bid, with a judge saying the failure to identify what exactly went wrong “may not be fatal” to the case.
SkyCity may be the first company to test the strength of AUSTRAC's claims in court, according to a judge who recently said in a separate case that the regulator's habit of agreeing to penalties could give rise to a "moral hazard".
A junior doctor representing thousands of medical officers in NSW has thwarted an application by the state to declass her group proceeding, with a judge saying a "single determination" of the issues common to all group members was the most efficient way of resolving them.
A court has imposed a $40 million penalty on Insurance Australia Limited in a case by the corporate regulator alleging NRMA customers were not paid $60 million in promised loyalty discounts.
Drug maker Sanofi-Aventis is not liable for the federal government’s losses for excess subsidies paid for the blood-thinner Plavix after an allegedly unjustified court injunction prevented the release of a generic version of the blockbuster drug, an appeals court has found.